In the healthcare industry, over $700 million is spent annually on lobbying, with top firms like Pharmaceutical Research and Manufacturers of America (PhRMA) and American Medical Association (AMA) leading the charge. Major companies, including Pfizer, Johnson & Johnson, and UnitedHealth Group, heavily invest in influencing policy to benefit their interests. These lobbying efforts shape healthcare legislation, often resulting in higher drug prices and insurance costs for the public, while ensuring profitable outcomes for the industry players.